These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22779790)

  • 1. Molecular features for antitrypanosomal activity of thiosemicarbazones revealed by OPS-PLS QSAR studies.
    Lozano NB; Maltarollo VG; Weber KC; Honorio KM; Guido RV; Andricopulo AD; Da Silva AB
    Med Chem; 2012 Nov; 8(6):1045-56. PubMed ID: 22779790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain.
    Espíndola JW; Cardoso MV; Filho GB; Oliveira E Silva DA; Moreira DR; Bastos TM; Simone CA; Soares MB; Villela FS; Ferreira RS; Castro MC; Pereira VR; Murta SM; Sales Junior PA; Romanha AJ; Leite AC
    Eur J Med Chem; 2015 Aug; 101():818-35. PubMed ID: 26231082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of New Thiosemicarbazones and Semicarbazones Containing the 1,2,3-1H-triazole-isatin Scaffold: Trypanocidal, Cytotoxicity, Electrochemical Assays, and Molecular Docking.
    Silva BNM; Sales Junior PA; Romanha AJ; Murta SMF; Lima CHS; Albuquerque MG; D'Elia E; Rodrigues JGA; Ferreira VF; Silva FC; Pinto AC; Silva BV
    Med Chem; 2019; 15(3):240-256. PubMed ID: 30332972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death.
    Magalhaes Moreira DR; de Oliveira AD; Teixeira de Moraes Gomes PA; de Simone CA; Villela FS; Ferreira RS; da Silva AC; dos Santos TA; Brelaz de Castro MC; Pereira VR; Leite AC
    Eur J Med Chem; 2014 Mar; 75():467-78. PubMed ID: 24561675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain.
    Du X; Guo C; Hansell E; Doyle PS; Caffrey CR; Holler TP; McKerrow JH; Cohen FE
    J Med Chem; 2002 Jun; 45(13):2695-707. PubMed ID: 12061873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships for a class of selective inhibitors of the major cysteine protease from Trypanosoma cruzi.
    Guido RV; Trossini GH; Castilho MS; Oliva G; Ferreira EI; Andricopulo AD
    J Enzyme Inhib Med Chem; 2008 Dec; 23(6):964-73. PubMed ID: 19005945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitrypanasomal activity of novel benzaldehyde-thiosemicarbazone derivatives from kaurenoic acid.
    Haraguchi SK; Silva AA; Vidotti GJ; dos Santos PV; Garcia FP; Pedroso RB; Nakamura CV; de Oliveira CM; da Silva CC
    Molecules; 2011 Jan; 16(2):1166-80. PubMed ID: 21270733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold(III) complexes with ONS-Tridentate thiosemicarbazones: Toward selective trypanocidal drugs.
    Rettondin AR; Carneiro ZA; Gonçalves AC; Ferreira VF; Oliveira CG; Lima AN; Oliveira RJ; de Albuquerque S; Deflon VM; Maia PI
    Eur J Med Chem; 2016 Sep; 120():217-26. PubMed ID: 27191616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.
    Greenbaum DC; Mackey Z; Hansell E; Doyle P; Gut J; Caffrey CR; Lehrman J; Rosenthal PJ; McKerrow JH; Chibale K
    J Med Chem; 2004 Jun; 47(12):3212-9. PubMed ID: 15163200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo trypanocidal activity of 1-(2-hydroxybenzylidene)thiosemicarbazide against Trypanosoma equiperdum.
    Parra N; Jaume M; Boscán K; Hernández A; Mijares A; González M; Alvarado Y; Restrepo J
    Vet Parasitol; 2017 Oct; 245():163-167. PubMed ID: 28935118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary Quantitative Structure⁻Activity Relationship Models for the Antitrypanosomal Activity of Sesquiterpene Lactones.
    Kimani NM; Matasyoh JC; Kaiser M; Nogueira MS; Trossini GHG; Schmidt TJ
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30467296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiosemicarbazones derived from 1-indanones as new anti-Trypanosoma cruzi agents.
    Caputto ME; Fabian LE; Benítez D; Merlino A; Ríos N; Cerecetto H; Moltrasio GY; Moglioni AG; González M; Finkielsztein LM
    Bioorg Med Chem; 2011 Nov; 19(22):6818-26. PubMed ID: 22000947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity on Trypanosoma cruzi, erythrocytes lysis and biologically relevant physicochemical properties of Pd(II) and Pt(II) complexes of thiosemicarbazones derived from 1-indanones.
    Santos D; Parajón-Costa B; Rossi M; Caruso F; Benítez D; Varela J; Cerecetto H; González M; Gómez N; Caputto ME; Moglioni AG; Moltrasio GY; Finkielsztein LM; Gambino D
    J Inorg Biochem; 2012 Dec; 117():270-6. PubMed ID: 23063173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antiparasitic activity of new thiosemicarbazones in strains of Trypanosoma cruzi.
    Moreno-Rodríguez A; Salazar-Schettino PM; Bautista JL; Hernández-Luis F; Torrens H; Guevara-Gómez Y; Pina-Canseco S; Torres MB; Cabrera-Bravo M; Martinez CM; Pérez-Campos E
    Eur J Med Chem; 2014 Nov; 87():23-9. PubMed ID: 25238291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of 2-acetylpyridine thiosemicarbazones against Trypanosoma rhodesiense in vitro.
    Casero RA; Klayman DL; Childs GE; Scovill JP; Desjardins RE
    Antimicrob Agents Chemother; 1980 Aug; 18(2):317-22. PubMed ID: 7447409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiprotozoal QSAR modelling for trypanosomiasis (Chagas disease) based on thiosemicarbazone and thiazole derivatives.
    Nossa González DL; Gómez Castaño JA; Rozo Núñez WE; Duchowicz PR
    J Mol Graph Model; 2021 Mar; 103():107821. PubMed ID: 33333422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing Potential Antitrypanosomal Thiazol-2-ethylamines through Predictive Regression Based and Classification Based QSAR Analyses.
    Amin SA; Adhikari N; Bhargava S; Jha T; Gayen S
    Curr Drug Discov Technol; 2017; 14(1):39-52. PubMed ID: 27855598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of new aryl thiosemicarbazone as antichagasic candidates.
    Blau L; Menegon RF; Trossini GH; Molino JV; Vital DG; Cicarelli RM; Passerini GD; Bosquesi PL; Chin CM
    Eur J Med Chem; 2013 Sep; 67():142-51. PubMed ID: 23851115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors.
    Pauli I; Ferreira LG; de Souza ML; Oliva G; Ferreira RS; Dessoy MA; Slafer BW; Dias LC; Andricopulo AD
    Future Med Chem; 2017 May; 9(7):641-657. PubMed ID: 28509592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of bioisosterism in design of the semicarbazone derivatives as cruzain inhibitors: a theoretical and experimental study.
    Vital DG; Damasceno FS; Rapado LN; Silber AM; Vilella FS; Ferreira RS; Maltarollo VG; Trossini GH
    J Biomol Struct Dyn; 2017 May; 35(6):1244-1259. PubMed ID: 27064715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.